(Q37766224)

22 August 2017

1 reference

title

Identification of cancer autoantigens in serum: toward diagnostic/prognostic testing? (English)

1 reference

22 August 2017

0 references

2

1 reference

22 August 2017

J Ignacio Casal

1

1 reference

22 August 2017

publication date

1 June 2010

1 reference

Molecular Diagnosis and Therapy

22 August 2017

published in

1 reference

22 August 2017

volume

14

1 reference

22 August 2017

issue

3

1 reference

22 August 2017

page(s)

149-154

1 reference

https://scigraph.springernature.com/pub.10.1007/bf03256367

22 August 2017

exact match

0 references

cites work

The sentinel within: exploiting the immune system for cancer biomarkers

1 reference

https://api.crossref.org/works/10.1007%2FBF03256367

Cell surface antigens of human malignant melanoma. III. Recognition of autoantibodies with unusual characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256367

Diagnostic markers of ovarian cancer by high-throughput antigen cloning and detection on arrays.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256367

Identification of differentially expressed proteins in ovarian cancer using high-density protein microarrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256367

Application of protein microarrays for multiplexed detection of antibodies to tumor antigens in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256367

Identification of tumor-associated autoantigens for the diagnosis of colorectal cancer in serum using high density protein microarrays.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256367

Microarrays of tumor cell derived proteins uncover a distinct pattern of prostate cancer serum immunoreactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256367

Cancer immunomics: using autoantibody signatures in the early detection of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256367

Autoantibody signatures in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256367

Human neoplasms elicit multiple specific immune responses in the autologous host

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256367

A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256367

An autoantibody-mediated immune response to calreticulin isoforms in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256367

Protein microarrays for gene expression and antibody screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256367

Development of natural protein microarrays for diagnosing cancer based on an antibody response to tumor antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256367

Using protein microarray as a diagnostic assay for non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256367

Fingerprinting the circulating repertoire of antibodies from cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256367

A human cDNA library for high-throughput protein expression screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256367

Self-assembling protein microarrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256367

Next-generation high-density self-assembling functional protein arrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256367

Autoantibodies to tumor-associated antigens: reporters from the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256367

Detection of a transformation-related antigen in chemically induced sarcomas and other transformed cells of the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256367

p53 autoantibodies as potential detection and prognostic biomarkers in serous ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256367

Autoantibody profiles reveal ubiquilin 1 as a humoral immune response target in lung adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256367

Occurrence of autoantibodies to annexin I, 14-3-3 theta and LAMR1 in prediagnostic lung cancer sera

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256367

Humoral response profiling reveals pathways to prostate cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256367

Seromic profiling of ovarian and pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256367

A common repertoire of autoantibodies is shared by cancer and autoimmune disease patients: Inflammation in their induction and impact on tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256367

Epitope landscape in breast and colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256367

Identification of tumor antigens in renal cell carcinoma by serological proteome analysis

21 January 2018

1 reference

12 December 2020

Towards a cancer immunome database

1 reference

12 December 2020

Recursive partitioning as an approach to selection of immune markers for tumor diagnosis

1 reference

12 December 2020

Immunotheranostics: breaking tolerance in immunotherapy using tumor autoantigens identified on protein microarrays.

1 reference

12 December 2020

Enhancement of antibody detection in cancer using panel of recombinant tumor-associated antigens.

1 reference

12 December 2020

Proteomic analysis of lung adenocarcinoma: identification of a highly expressed set of proteins in tumors.

1 reference

12 December 2020

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03256367

1 reference

22 August 2017

1 reference